Modifiable pathways in Alzheimer's disease: Mendelian randomisation analysis.

Larsson SC, Traylor M, Malik R, Dichgans M, Burgess S, Markus HS, CoSTREAM Consortium, on behalf of the International Genomics of Alzheimer’s Project. · 2017

Read Modifiable pathways in Alzheimer's disease: Mendelian randomisation analysis. by Larsson SC, Traylor M, Malik R, Dichgans M, Burgess S, Markus HS, CoSTREAM Consortium, on behalf of the International Genomics of Alzheimer’s Project. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5717765.txt.

Introduction

Larsson and co-authors test which changeable risk factors may help cause Alzheimer's disease. They use Mendelian randomisation, a method that uses genes as stand-ins for each factor. This design cuts the bias that can distort plain health surveys.

The study draws on the International Genomics of Alzheimer's Project. It covers 17,008 cases and 37,154 controls, and checks 24 factors in all. These span schooling, habits, diet, heart and metabolic health, and inflammation. Genetically predicted schooling links clearly to a lower risk of the disease. Signs for intelligence, smoking, vitamin D, and coffee were weaker and less sure. Most heart, metabolic, and blood factors showed no link. The results support more schooling as one route to lower risk.

Catalog record

CREATORLarsson SC, Traylor M, Malik R, Dichgans M, Burgess S, Markus HS, CoSTREAM Consortium, on behalf of the International Genomics of Alzheimer’s Project.
YEAR2017
COLLECTIONPAPERS
FORMATTXT
FILE SIZE41 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5717765

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Modifiable pathways in Alzheimer’s disease: Mendelian randomisation analysis By Susanna C Larsson, Matthew Traylor, Rainer Malik, Martin Dichgans, Stephen Burgess, Hugh S Markus Published in: The BMJ DOI: 10.1136/bmj.j5375 ABSTRACT Abstract Objective To determine which potentially modifiable risk factors, including socioeconomic, lifestyle/dietary, cardiometabolic, and inflammatory factors, are associated with Alzheimer’s disease. Design Mendelian randomisation study using genetic variants associated with the modifiable risk factors as instrumental variables. Setting International Genomics of Alzheimer’s Project. Participants 17 008 cases of Alzheimer’s disease and 37 154 controls. Main outcome measures Odds ratio of Alzheimer’s per genetically predicted increase in each modifiable risk factor estimated with Mendelian randomisation analysis. Results This study included analyses of 24 potentially modifiable risk factors. A Bonferroni corrected threshold of P=0.002 was considered to be significant, and P<0.05 was considered suggestive of evidence for a potential association. Genetically predicted educational attainment was significantly associated with Alzheimer’s. The odds ratios were 0.89 (95% confidence interval 0.84 to 0.93; P=2.4×10−6) per year of education completed and 0.74 (0.63 to 0.86; P=8.0×10−5) per unit increase in log odds of having completed college/university. The correlated trait intelligence had a suggestive association with Alzheimer’s (per genetically predicted 1 SD higher intelligence: 0.73, 0.57 to 0.93; P=0.01). There was suggestive evidence for potential associations between genetically predicted higher quantity of smoking (per 10 cigarettes a day: 0.69, 0.49 to 0.99; P=0.04) and 25-hydroxyvitamin D concentrations (per 20% higher levels: 0.92, 0.85 to 0.98; P=0.01) and lower odds of Alzheimer’s and between higher coffee consumption (per one cup a day: 1.26, 1.05 to 1.51; P=0.01) and higher odds of Alzheimer’s. Genetically predicted alcohol consumption, serum folate, serum vitamin B12, homocysteine, cardiometabolic factors, and C reactive protein were not associated with Alzheimer’s disease. Conclusion These results provide support that higher educational attainment is associated with a reduced risk of Alzheimer’s disease. INTRODUCTION Alzheimer’s disease is the leading cause of dementia. The chief hallmarks are amyloid plaques and neurofibrillary tangles.1 The amyloid cascade hypothesis implies that accumulation of amyloid β triggers neuronal dysfunction and cell death in the brain.1 An alternative theory—the vascular hypothesis—implicates cerebral hypoperfusion as the primary trigger; this drives oxidative stress, deposition of amyloid β, neuroinflammation, blood-brain barrier breakdown, cognitive decline, and neurodegeneration.2 3 Apart from increasing age and the apolipoprotein E (APOE) e4 allele, the causes of Alzheimer’s disease are largely unknown, and treatment trials have been disappointing.4 This has led to increasing interest in the potential for reducing Alzheimer’s by targeting modifiable risk factors. Conventional observational studies have consistently shown that low educational attainment is associated with an increased risk,5 and it has been estimated that 19% of cases are potentially attributable to low education.6 Inconclusive evidence from conventional observational studies indicates that obesity, hypertension, and hypercholesterolaemia in midlife and diabetes, smoking, low vitamin D and folate concentrations, hyperhomocysteinaemia, and high C reactive protein concentrations are associated with increased risk, whereas physical activity, a healthy diet, moderate alcohol drinking, and coffee consumption are associated with decreased risk (table A in appendix 1).5 6 7 8 9 10 11 A 2010 State of the Science report concluded that there was insufficient evidence to support the association with any modifiable factors with risk.7 Available evidence is in large part inadequate as observational studies generally rely on self reported information and are susceptible to confounding and reverse causation bias, and data from randomised trials12 13 14 15 16 are scarce and inconclusive. Mendelian randomisation is a genetic epidemiological method for assessing causal inference by exploiting genetic variants influencing the modifiable risk factor to estimate the unbiased association between the risk factor and risk of disease. Genetic alleles are randomly assorted during conception and thus are less likely to be affected by confounding factors that could bias the observational findings. Furthermore, reverse causation bias is avoided because genotype is not affected by disease. This method is being increasingly used to investigate the potential of different treatment approaches by determining which risk factors are causally associated with disease and therefore might be worth targeting therapeutically.17 To decipher potentially causal and modifiable risk factors we applied a Mendelian randomisation approach to examine the associations between multiple potentially modifiable risk factors and Alzheimer’s disease. METHODS Modifiable risk factors We considered potentially modifiable risk factors that can be grouped under the following categories: socioeconomic, lifestyle/dietary, cardiometabolic, and inflammatory. Within these categories we focused on factors that were identified as having the most consistent evidence for an association with Alzheimer’s disease in meta-analyses of prospective observational studies (table A in appendix 1).5 8 9 10 11 We also included intelligence on the basis of its strong genetic correlation with educational attainment18 and to increase the number of proxies of cognitive reserve.19 20 Data sources We performed this analysis with summarised data (effect size estimates and their standard errors) from published genome-wide association studies (fig A in appendix 2). We searched PubMed for genome-wide association studies of the modifiable risk factors and identified genetic variants with genome-wide significant (P <5×10−8) associations for educational attainment (years of education completed and college/university completion),21 intelligence,18 smoking (quantity, initiation, and cessation),22 23 alcohol24 and coffee25 consumption, 25-hydroxyvitamin D (25(OH)D; the primary biomarker of vitamin D status),26 serum folate and vitamin B12 concentrations,27 total homocysteine,28 overall obesity (body mass index (BMI)),29 abdominal obesity (waist to hip ratio adjusted for BMI),30 type 2 diabetes,31 fasting glucose and insulin,32 systolic and diastolic blood pressure,33 blood lipids (high density lipoprotein cholesterol, low density lipoprotein cholesterol, total cholesterol, and triglycerides),34 and C reactive protein (a general marker of systemic inflammation).35 We did not identify genetic variants with genome-wide significant association with occupation or income (measures of socioeconomic status), physical activity, healthy eating patterns, or vitamins C or E. Details on the risk factor studies from which we obtained summarised data for the current analyses from are presented in table B in appendix 1. Summarised data for the associations between the genetic variants (that is, the single nucleotide polymorphisms) related to risk factors and Alzheimer’s disease were obtained from the International Genomics of Alzheimer’s Project (IGAP), which has been described elsewhere.36 Briefly, this project includes data from 17 008 cases of Alzheimer’s disease and 37 154 controls of European ancestry from four genome-wide association study datasets, including the Alzheimer’s Disease Genetics Consortium (ADGC), the Cohorts for Heart and Aging Research in Genomic Epidemiology consortium (CHARGE), the European Alzheimer’s disease Initiative (EADI), and the Genetic and Environmental Risk in Alzheimer’s disease consortium (GERAD). Details on the original genetic analyses and diagnostic criteria for Alzheimer’s disease are provided in appendix 3. Summarised data for the associations of the genetic variants with the risk factors and Alzheimer’s disease are presented in table C in appendix 1. Patient involvement No patients were involved in the design of the study, recruitment, or conduct of the study. No patients were asked to advise on interpretation or writing up of results. There are no plans to involve patients in dissemination of the results, but results will, after scientific publication, be disseminated to the public in general. Genetic variants For each modifiable risk factor, we selected genetic variants (single nucleotide polymorphisms) associated with the risk factor at thresholds for genome-wide significance (P <5×10−8) in the sex combined meta-analysis of the discovery

Read the complete text